Galderma, a Swiss pharmaceutical company, completed the acquisition of Alastin Skincare, a physician-dispensed skincare brand. Financial terms were not disclosed. “I am so happy to officially welcome the ALASTIN team to Galderma. As a part of our integrated dermatology approach, we are continuously seeking to add products that synergize with our premium portfolio - and ALASTIN is the perfect fit. The ALASTIN brand’s proprietary and award-winning skincare technology, combined with Galderma’s world-class pipeline and innovation track record, represents an unparalleled opportunity for Galderma to better meet the needs of aesthetic professionals and patients, now and well into the future," Flemming Ørnskov, Galderma CEO.